[HTML][HTML] Engineering neoantigen vaccines to improve cancer personalized immunotherapy
Z Liu, J Lv, Q Dang, L Liu, S Weng, L Wang… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
Immunotherapy treatments harnessing the immune system herald a new era of personalized
medicine, offering considerable benefits for cancer patients. Over the past years, tumor …
medicine, offering considerable benefits for cancer patients. Over the past years, tumor …
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
E Blass, PA Ott - Nature reviews Clinical oncology, 2021 - nature.com
Within the past decade, the field of immunotherapy has revolutionized the treatment of many
cancers with the development and regulatory approval of various immune-checkpoint …
cancers with the development and regulatory approval of various immune-checkpoint …
Challenges in developing personalized neoantigen cancer vaccines
PD Katsikis, KJ Ishii, C Schliehe - Nature Reviews Immunology, 2024 - nature.com
The recent success of cancer immunotherapies has highlighted the benefit of harnessing the
immune system for cancer treatment. Vaccines have a long history of promoting immunity to …
immune system for cancer treatment. Vaccines have a long history of promoting immunity to …
Development of neoantigens: from identification in cancer cells to application in cancer vaccines
N Ebrahimi, M Akbari, M Ghanaatian… - Expert Review of …, 2022 - Taylor & Francis
Introduction The discovery of neoantigens as mutated proteins specifically expressed in
tumor cells but not in normal cells has led to improved cancer vaccines. Targeting …
tumor cells but not in normal cells has led to improved cancer vaccines. Targeting …
Recent development and clinical application of cancer vaccine: targeting neoantigens
RY Pan, WH Chung, MT Chu, SJ Chen… - Journal of …, 2018 - Wiley Online Library
Recently, increasing data show that immunotherapy could be a powerful weapon against
cancers. Comparing to the traditional surgery, chemotherapy or radiotherapy …
cancers. Comparing to the traditional surgery, chemotherapy or radiotherapy …
Neoantigen cancer vaccines: generation, optimization, and therapeutic targeting strategies
Alternatives to conventional cancer treatments are highly sought after for high-risk
malignancies that have a poor response to established treatment modalities. With research …
malignancies that have a poor response to established treatment modalities. With research …
Designing neoantigen cancer vaccines, trials, and outcomes
Neoantigen vaccines are based on epitopes of antigenic parts of mutant proteins expressed
in cancer cells. These highly immunogenic antigens may trigger the immune system to …
in cancer cells. These highly immunogenic antigens may trigger the immune system to …
Therapeutic vaccines targeting neoantigens to induce T-cell immunity against cancers
SC Pao, MT Chu, SI Hung - Pharmaceutics, 2022 - mdpi.com
Cancer immunotherapy has achieved multiple clinical benefits and has become an
indispensable component of cancer treatment. Targeting tumor-specific antigens, also …
indispensable component of cancer treatment. Targeting tumor-specific antigens, also …
Current trends in neoantigen-based cancer vaccines
SY Ho, CM Chang, HN Liao, WH Chou, CL Guo… - Pharmaceuticals, 2023 - mdpi.com
Cancer immunotherapies are treatments that use drugs or cells to activate patients' own
immune systems against cancer cells. Among them, cancer vaccines have recently been …
immune systems against cancer cells. Among them, cancer vaccines have recently been …
Identification of neoantigens for individualized therapeutic cancer vaccines
Somatic mutations in cancer cells can generate tumour-specific neoepitopes, which are
recognized by autologous T cells in the host. As neoepitopes are not subject to central …
recognized by autologous T cells in the host. As neoepitopes are not subject to central …